Aptorum Group Limited Reports 2020 Fiscal Year End Financial Results and Provides Business Update
Aptorum Group Limited Reports 2020 Fiscal Year End Financial Results and Provides Business Update Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology and infectious diseases, today announced financial results for the fiscal year ended December 31, 2020, and provided an update on clinical and corporate developments. Mr. Darren Lui, President and Executive Director of Aptorum Group Limited, commented "Aptorum's operational plans remain on track. In particular, one of our lead programs, ALS-4 (t...
Source: finanznachrichten.de